| Vendor | |
|---|---|
|
Mohrbooks Literary Agency
Sebastian Ritscher |
| Original language | |
| English | |
| Categories | |
BLOOD MONEY
The Story of Life, Death, and Profit Inside America's Blood Industry
Bad Blood meets Dreamland in this kaleidoscopic investigation into the business of selling blood. Taking us from China's blood black market to Silicon Valley's shadowy tech startups, this is an unforgettable inside look at an industry many of us had no idea even existed.
Every year, about twenty million Americans sell blood plasma for cash in a barely regulated market dominated by private industry and off-the-grid trafficking. These commercial efforts prey on an insatiable market for medical and scientific innovation fed from the veins of some of the country's most marginalized communities, such as undocumented immigrants and residents of poverty-stricken Flint, Michigan.
We are often told that "blood donations" are used to save lives, but blood plasma, a component of whole blood, has become a precious commercial good. Blood plasma is collected and marketed by private industry, with the United States one of just five nations on the planet that have not yet banned the practice of pay-for-plasma giving. This precious resource is used for everything from expensive and unproven age-reversing treatments to costly and experimental cures for novel diseases like COVID-19.
Based on a cross-country investigation into the plasma-giving capitals of the country, in-depth research into the blood industry, and her personal experience as a beneficiary of plasma-derived treatment for a rare condition, Kathleen McLaughlin's Blood Money reveals the underhanded machinations and unbalanced power structures of the blood industry. This is an electrifying exposé that demonstrates the shadowy overlap between big medicine and big business and paints a searing portrait of the extent to which American industry feeds on the country's most vulnerable.
Kathleen McLaughlin is an award-winning journalist who reports and writes about the consequences of economic inequality around the world. A frequent contributor to The Washington Post and The Guardian, McLaughlin's reporting has also appeared in The New York Times, BuzzFeed, The Atlantic, The Economist, NPR, and more. She is a former Knight Science Journalism fellow at MIT and has won multiple awards for her reporting on labor in China. Blood Money is her first book.
We are often told that "blood donations" are used to save lives, but blood plasma, a component of whole blood, has become a precious commercial good. Blood plasma is collected and marketed by private industry, with the United States one of just five nations on the planet that have not yet banned the practice of pay-for-plasma giving. This precious resource is used for everything from expensive and unproven age-reversing treatments to costly and experimental cures for novel diseases like COVID-19.
Based on a cross-country investigation into the plasma-giving capitals of the country, in-depth research into the blood industry, and her personal experience as a beneficiary of plasma-derived treatment for a rare condition, Kathleen McLaughlin's Blood Money reveals the underhanded machinations and unbalanced power structures of the blood industry. This is an electrifying exposé that demonstrates the shadowy overlap between big medicine and big business and paints a searing portrait of the extent to which American industry feeds on the country's most vulnerable.
Kathleen McLaughlin is an award-winning journalist who reports and writes about the consequences of economic inequality around the world. A frequent contributor to The Washington Post and The Guardian, McLaughlin's reporting has also appeared in The New York Times, BuzzFeed, The Atlantic, The Economist, NPR, and more. She is a former Knight Science Journalism fellow at MIT and has won multiple awards for her reporting on labor in China. Blood Money is her first book.
| Available products |
|---|
|
Book
Published 2023-01-24 by One Signal / Atria |